Newsletter | December 14, 2024

12.14.24 -- 2024 Survey Findings: How Is The "Lab Of The Future" Becoming Reality?

FEATURED EDITORIAL

2024 Survey Findings: How Is The "Lab Of The Future" Becoming Reality?

The Pistoia Alliance conducted a survey as a pulse check on which technologies the pharma/biotech industry is investing in and companies' progress integrating new tech into the lab.

INDUSTRY INSIGHTS

Application Of A Novel Temperature Shift Process For Particle Engineering

Spray drying of amorphous dispersions improves solubility and bioavailability that enables supersaturation in the intestine, driving higher rates of absorption.

Continuous Manufacturing: An Evolving Technology For Drug Substance Manufacturing

Discover the exciting developments in continuous manufacturing and learn how leveraging this innovative technology can help improve manufacturing processes and discover new clinical candidates.

In Vitro Dissolution Methodologies For Amorphous Solid Dispersions

With the availability of so many types of in vitro dissolution tests, how do you determine which one will be most effective in predicting in vivo performance of your BCS II or IV drug product?

Reducing Environmental Impact At All Stages Of The Medicine Journey

Explore how utilizing technologies like AI and digital twinning can inform decision-making at the R&D stage and how to optimize the delivery of the final drug product to patients with greener logistics.

Modeling Colorectal Cancer Progression

Explore the microenvironment's role in colorectal cancer progression by reviewing the integration of Organ-Chip models with high-content imaging and mass spectrometry-based metabolomics.

Mitigating Hidden Risks: Extractables And Leachables

Everything from glass or plastic bottles to the ink used in labels can leach unwanted contaminants. The first challenge chemists address is to narrow the focus on the most likely suspects.

Using Parallel Operations In Biopharma Manufacturing

One solution to drug development challenges is adopting a parallel operations business model. Review recommendations for how parallel operations can be leveraged in a biomanufacturing strategy.

Advanced Analytical Tools To De-Risk Pharmaceutical Development

Discover three tools that facilitate a successful journey from candidate compound to clinical triumph: solid form screening, PBPK modeling, and AI-enabled route scouting.

Developing A Sterilizing Grade Filter For High Concentration Biologics

Explore an approach to developing a sterilizing-grade filter for high-concentration biologics that enabled extensive filterability trials to be conducted without needing a large quantity of product.

MOST POPULAR NEWS

Beckman Coulter Life Sciences Launches Cydem VT Automated Clone Screening System

XtalPi Leverages AWS To Enhance Drug Discovery

Congruence & Ono Announce Multi-Target Research Collaboration

SoftServe Debuts 'Drug Discovery,' Built With NVIDIA Blueprints At AWS Re:Invent 2024

New Understanding Of A Cancer Relevant Protein Reveals Opportunities For Drug Discovery

Breakthrough 3D Printing Technology Could Bring End Of Animal Drug Testing A Step Closer

Cytokinetics Announces FDA Acceptance Of NDA For Aficamten

Duality Biologics & GSK Enter Exclusive Option Agreement For A Novel ADC (DB-1324)

Saol Therapeutics Announces Submission Of NDA To The U.S. FDA For SL1009

Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation From FDA

Novel All-In-One Computational Pipeline Identifies Protein Biomarkers Associated With Alzheimer's Disease

SOLUTIONS

Protein Characterization And Biosafety Testing Services

Biopharmaceutical Services

Curia Capacity Update October 2024: Large Molecule Drug Substance

Lonza Capacity Update October 2024: Small Molecule